Latest Articles
- Vitamin D and the heart: Why we need large-scale clinical trials
Despite enthusiasm for vitamin D, no large-scale primary prevention trial has used cardiovascular disease or cancer as a prespecified primary outcome.
- MAO inhibitors: Risks, benefits, and lore
Monoamine oxidase inhibitors were the first antidepressants introduced. Interest in their use is reviving.
- Bariatric surgery, vitamin C, and kidney stones (July 2010)
Readers comment on nutritional supplementation after bariatric surgery (July 2010) and on glucocorticoid-induced osteoporosis (August 2010).
- Glucocorticoid-induced osteoporosis (August 2010)
Readers comment on nutritional supplementation after bariatric surgery (July 2010) and on glucocorticoid-induced osteoporosis (August 2010).
- Approach to a low TSH level: Patience is a virtue
Confronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
- How to prevent glucocorticoid-induced osteoporosis (August 2010)
Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).
- Should anticoagulation be resumed after intracerebral hemorrhage?
In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.